Kedrion Biopharma
Giacomo Bertagni possesses extensive experience in marketing and planning within the biopharmaceutical industry, currently serving as Manager for Marketing LATAM AMEA & Turkey at Kedrion Biopharma since September 2014. Previous roles at Kedrion Biopharma include Marketing Manager for Asia, Middle East, and Africa, as well as specialist and planner positions in global planning and supply management. Prior to Kedrion, Bertagni worked as a Junior Project Manager at GIS system engineering s.r.l. Educational qualifications include a Master's degree in Business Consulting from Università di Pisa, a Master's degree in Pharmaceutical Marketing from PIN - Polo Universitario Città di Prato, and an Advanced Project Management Master's degree from Accademia Executive in Pisa, Italy. Additional foundational education includes a Bachelor’s degree in Business/Managerial Economics from Università di Pisa and studies at Liceo Scientifico Galileo Galilei.
This person is not in any teams
Kedrion Biopharma
19 followers
Kedrion Biopharma is a biopharmaceutical company that collects and fractionates blood plasma to produce and distribute worldwide plasma-derived therapies for use in treating and preventing rare and serious diseases and conditions. In 2022, Kedrion joined forces with BPL (Bio Products Laboratory). Based in the United Kingdom, BPL has over 60 years of experience in the supply of high-quality plasma-derived medicines to treat rare diseases. Kedrion distributes its products in over 100 countries around the world. We have plants in Italy, Hungary, UK and North America, and plasma collection centers in the US and in the Czech Republic. With these figures we are the world’s 5th top player in the field of plasma-derived products. Our goal is to build a diverse and professional workforce, providing job opportunities for talented external candidates as well as internal employees who aim to grow with us. Because our work includes so many interests and skills – from Research to Sales; Plasma Collection to Production – there are abundant possibilities for learning and growth. Kedrion builds bridges: from donors to patients, from plasma to therapies, from challenge to hope.